Evidence map›Paper›PMID 22313876›Full record

ReviewSeminars in cancer biology2012

Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells.

Srinivas Nagaraj, Dmitry I Gabrilovich

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in cancer biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Focus on Pancreatic Cancer Microenvironment.Current oncology (Toronto, Ont.) · 2024
    Review
  12. T Cell Development and Function.Rejuvenation research · 2023
    Review
  13. Review
  14. Immune checkpoint inhibitors in ovarian cancer: where do we go from here?Cancer drug resistance (Alhambra, Calif.) · 2023
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Srinivas NagarajDepartment of Internal Medicine, University of South Florida, Tampa, FL 33612, United States. snagaraj@health.usf.edu
Dmitry I Gabrilovich
University of South Florida · US

Funding

Correction of myeloid cell defects in cancerR01CA084488 · NCI · WISTAR INSTITUTE · PI GABRILOVICH, DMITRY I · 1999 to 2017
$5.4M
Mechanism of myeloid cell defect in cancerR01CA100062 · NCI · WISTAR INSTITUTE · PI GABRILOVICH, DMITRY I · 2004 to 2018
$4.0M
Nanomedicine Research Center Core (NRCC)P30HL101265 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI MOHAPATRA, SHYAM S · 2009 to 2010
$1.3M
NCI NIH HHS CA84488NCI NIH HHS R01 CA084488NCI NIH HHS R01 CA100062NHLBI NIH HHS 1P30HL101265-01NHLBI NIH HHS P30 HL101265
6 · The paper itself

Abstract

Myeloid derived suppressor cells play a critical role in T cell suppression in cancer. Here, we discuss the mechanisms of how MDSC suppress CD4(+) or CD8(+) T cells in an antigen dependent or non-dependent manner.

Indexed as

AnimalsAntigens, NeoplasmCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHumansImmune ToleranceMyeloid CellsNeoplasmsTumor EscapeAntigens, Neoplasm

Identifiers

PMID22313876
PMCPMC3349790
OpenAlexW2065000646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.